The International Journal of Alzheimer's Disease focuses on research related to Alzheimer's disease (AD), including its diagnosis, treatment, and the underlying biological mechanisms. The journal covers topics such as the development and validation of biomarkers for early detection, the efficacy and challenges of therapeutic interventions including drug repurposing and immunotherapy, and the investigation of genetic and environmental factors like the gut microbiome and phytochemicals. It also addresses the impact of AD on patients and caregivers, and the use of various research methodologies from clinical trials and observational studies to computational and animal models.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2017
2018
2019
2020
2021
2022
2023
2024
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
NeurologyQ2
Neurology (clinical)Q2
AgingQ3
Behavioral NeuroscienceQ3
Cellular and Molecular NeuroscienceQ3
Cognitive NeuroscienceQ3
Subject Classification
Scopus Categories
Neurology (clinical)AgingCellular and Molecular NeuroscienceCognitive NeuroscienceBehavioral NeuroscienceNeurology
Research Topics (OpenAlex)
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery MethodsNeuroinflammation and Neurodegeneration MechanismsFunctional Brain Connectivity StudiesNeuroscience and Neuropharmacology ResearchTrace Elements in HealthNeurological Disease Mechanisms and TreatmentsNuclear Receptors and Signaling